NO995032L - Basis-sammensetning for perkutan absorpsjon og perkutant absorberbart preparat inneholdende basis-sammensetningen - Google Patents

Basis-sammensetning for perkutan absorpsjon og perkutant absorberbart preparat inneholdende basis-sammensetningen

Info

Publication number
NO995032L
NO995032L NO995032A NO995032A NO995032L NO 995032 L NO995032 L NO 995032L NO 995032 A NO995032 A NO 995032A NO 995032 A NO995032 A NO 995032A NO 995032 L NO995032 L NO 995032L
Authority
NO
Norway
Prior art keywords
base composition
percutaneous absorption
percutaneously absorbable
preparation containing
absorbable preparation
Prior art date
Application number
NO995032A
Other languages
English (en)
Norwegian (no)
Other versions
NO995032D0 (no
Inventor
Masayoshi Maki
Munehiko Hirano
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of NO995032D0 publication Critical patent/NO995032D0/no
Publication of NO995032L publication Critical patent/NO995032L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A61F2013/0296—Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO995032A 1997-04-16 1999-10-15 Basis-sammensetning for perkutan absorpsjon og perkutant absorberbart preparat inneholdende basis-sammensetningen NO995032L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11525497 1997-04-16
PCT/JP1998/001745 WO1998046267A1 (fr) 1997-04-16 1998-04-16 Composition de base pour absorption percutanee, preparation destinee a cette absorption et renfermant ladite composition

Publications (2)

Publication Number Publication Date
NO995032D0 NO995032D0 (no) 1999-10-15
NO995032L true NO995032L (no) 1999-10-15

Family

ID=14658143

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995032A NO995032L (no) 1997-04-16 1999-10-15 Basis-sammensetning for perkutan absorpsjon og perkutant absorberbart preparat inneholdende basis-sammensetningen

Country Status (8)

Country Link
EP (1) EP0976405A4 (id)
CN (1) CN1252004A (id)
AU (1) AU723018B2 (id)
BR (1) BR9808594A (id)
CA (1) CA2287463A1 (id)
ID (1) ID23512A (id)
NO (1) NO995032L (id)
WO (1) WO1998046267A1 (id)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5943201A (en) * 2000-05-03 2001-11-12 Amgen Inc Modified peptides as therapeutic agents
JP2001328935A (ja) 2000-05-19 2001-11-27 Hisamitsu Pharmaceut Co Inc 貼付剤
DE10236319A1 (de) * 2002-08-08 2004-02-19 Beiersdorf Ag Hautfreundliche Wirkstoffpflaster auf der Basis von SBC mit mindestens einem pharmazeutischen Wirkstoff mit einem Gehalt von mindestens 34 Gew.-% und dessen Herstellung
KR100704825B1 (ko) 2003-02-21 2007-04-09 바이엘 쉐링 파마 악티엔게젤샤프트 Ｕｖ 안정성 경피 치료 플라스터
JP4422430B2 (ja) 2003-05-14 2010-02-24 帝國製薬株式会社 エストロゲン及び／又はプロゲストゲン含有外用貼付剤
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248676A (en) * 1990-05-17 1993-09-28 Hisamitsu Pharmaceutical Co., Inc. Estradiol percutaneous administration preparations
JP2971224B2 (ja) * 1991-11-30 1999-11-02 久光製薬株式会社 エストラジオール経皮吸収貼付剤
JPH0853338A (ja) * 1994-08-11 1996-02-27 Shiseido Co Ltd 皮膚外用剤
EP0746311B1 (en) * 1994-12-24 2001-07-11 Pacific Corporation Medicinal patches for percutaneous administration

Also Published As

Publication number Publication date
EP0976405A4 (en) 2000-12-06
AU6852598A (en) 1998-11-11
NO995032D0 (no) 1999-10-15
BR9808594A (pt) 2000-05-23
EP0976405A1 (en) 2000-02-02
ID23512A (id) 2000-04-27
CA2287463A1 (en) 1998-10-22
CN1252004A (zh) 2000-05-03
WO1998046267A1 (fr) 1998-10-22
AU723018B2 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
ATE108329T1 (de) Morphin enthaltende zusammensetzung.
DK1035833T3 (da) Sammensætning til nasal indgivelse
IT8947938A0 (it) Adsorbati di resina, procedimento per prepararli e composizioni farmaceutiche che li contengono
FI895681A0 (fi) Farmaceutisk komposition foer systemisk transdermal tillfoersel.
DE69605940D1 (de) Wärmeaktivierbare klebstoffzusammensetzung
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
NO20000084D0 (no) Fenolisk harpiks for limblanding, fremstilling derav og limpreparat inneholdende harpiksen
NO962694D0 (no) Percutant farmasöytisk preparat
SE9704546D0 (sv) Novel compounds
AU2002300764A1 (en) Medical adhesive composition, medical adhesive tape using the same and tape preparation for percutaneous absorption
AU4710499A (en) Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds
FI98342B (fi) Pitkävaikutteinen viskoosinen liimautuva ehkäisykoostumus
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
ITTO910077A0 (it) Composizione indurente per colle urea-formaldeide, procedimento per lasua produzione e kit che la comprende.
FR2791985B1 (fr) Composition a base de 2-cyanoacrylate et adhesif, charge et materiau d'empotage comprenant cette composition
DE68918847D1 (de) Stabile pharmazeutische zusammensetzung.
IT1287174B1 (it) Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
SE9802937D0 (sv) Novel compounds
NO995032L (no) Basis-sammensetning for perkutan absorpsjon og perkutant absorberbart preparat inneholdende basis-sammensetningen
DE69016406D1 (de) Klebstoffzusammensetzung.
DE68918483D1 (de) Wasserquellfähige Harzzusammensetzung.
DE69708130D1 (de) A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung
DE68909636D1 (de) Adhäsive Zusammensetzung.
DE69001938D1 (de) Klebstoffzusammensetzung.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application